CUV - Clinuvel Pharmaceuticals

[Go Nuke]

Yeah what a load of BS in my opinion.

I mean dont get me wrong, Ive ben a holder of CUV for quite some timing but the sp having declined about 2/3's from what i bought in at.

They will surely get a ticket from the ASX for this.
Yes, this did happen in Aug and to a slightly lesser extent in Oct last year, before resuming its decline.
Perhaps its from people who have been shorting this stock for so long realised that it was about to turn around hence the reversal in the share price?

Does it work like that?
I don't know because Ive never shorted anything.
Anyway, if an announcement comes out then all the more sus in my opinion, however i think it will just turn out like the months of Aug and Oct 07.


(My inexperience means I'm still sitting on approx 50% loss even after today Oh well. learning as i go.)
And i thought now one followed this stock..lol.

 

[Go Nuke]

I dont know if anyone still follows this company or if I was the only one silly enough to buy and hold from $1, but I think the share price has found a good base of 32c with quite alot of share orders waiting to be filled for the buyers.

I also think that the sp chart looks like it was forming a bit of a "pan" shape.

Could finally be a positive outlook for the sp perhaps over the next few months?

 

[daaussie]

following it daily. nice announcement last week sent stock to 40 cents.

the price was crippled due to the general maket havok and US sub prime. Every1 is feeling it in many stocks across the board.

I agree with you that there is a barrier at about 35 cents. I have watched the stock daily, and in my view there looks like there will not be a low past 32.

I am holding from 43 cents, and dont have quite the loss u have GO NUKE, but I think this will be hit someday, dont know when though.

 

[shane101]

Afamelanotide, in my opinion has the potential to be 10 times bigger than Viagra. Ive been using this drug for around 4 years now. Its truly incredible. I'm more than happy to share my experience so far if anyone is interested.

 

[shane101]

Could somebody be so kind as to point me in the direction of another thread for CUV that's a bit more recent? Thanks.

 

[juxtaposer]

Been a while since this forum was active and CUV is sitting right on the edge of approval in EU following extremely successful phase 3 trials.

CUV is very well cashed up. The Italian Govt has already approved with full rebate of costs to to CUV for all of the EPP sufferers in Italy. EPP has a very small number of sufferers world wide. Next indication will be PLE which 10-20% of the population suffers from. Trials for other indications are well advanced.

Ultimately this will be of benefit to anyone with skin sensitive to burning in the sun. It is more effective of people with light (white) skin, ie Caucasians.
Possibly the most effective protection against sunburn and skin cancer yet devised, it stimulates the body's natural production of melanin.

Clinuvel's product is now know as Senesse and is focusing on medical conditions rather than the side effect of tanning.

Safety has been proved and efficacy is significant.

This could be approved in Europe any day now. Trials for FDA (US) approval are well advanced.

 

[Mauries]

CUV Clinuvel

CUV Clinuvel have disappeared off the ASX list> They were a valid company last week. Have they gone in to liquidation or been taken over?

 

[Happy]

http://clinuvel.com/

If it is their webpage, maybe you can find some answers here?

 

[ACE-03]

Re: CUV Clinuvel

CUV Clinuvel have disappeared off the ASX list> They were a valid company last week. Have they gone in to liquidation or been taken over?

Hi Mauries,

CUV's share price is bring consoliated. You can currently see the depth under CUVDA.

 

[Mauries]

Thanks
Have heard nothing from CUV about this. I would have thought the company would be obliged to notify its shareholders

 

[Pugt16]

Hey guys,
So first post, bringing a near 7 year old dead thread back to life is a great start! But it's better than starting a useless new thread i hope.

I've been looking into CUV for about a week now and i'm surprised by the apparent lack of interest in this company and this thread demonstrates this yet again. I'm a complete novice investor but i think (as does everyone else) that i can spot the next blockbuster when i see one.

What i understand about Clinuvels position is, EMA approval, possibly FDA approval in the next year and a decent market potential with a condition called EPP (just for appetisers). My question is, what are your feelings about CUV being the next big bio blockbuster, or have i missed a big piece of the puzzle?

Cheers.

 

[Knobby22]

Hey guys,
So first post, bringing a near 7 year old dead thread back to life is a great start! But it's better than starting a useless new thread i hope.

I've been looking into CUV for about a week now and i'm surprised by the apparent lack of interest in this company and this thread demonstrates this yet again. I'm a complete novice investor but i think (as does everyone else) that i can spot the next blockbuster when i see one.

What i understand about Clinuvels position is, EMA approval, possibly FDA approval in the next year and a decent market potential with a condition called EPP (just for appetisers). My question is, what are your feelings about CUV being the next big bio blockbuster, or have i missed a big piece of the puzzle?

Cheers.

Is it the same blockbuster as 8 years ago? if so, they are really slow.

 

[Pugt16]

Is it the same blockbuster as 8 years ago? if so, they are really slow.

I'm not sure what was happening 8 years ago. I was ready to buy some shares but i'm concerned the lack of interest means others are seeing what im not. I know a bit about pharmaceuticals and it seems they've got an effective, patented, approved drug. And as others here have said over a decade ago (haha) there's a lot of potential for such a drug.

 

[Knobby22]

I'm not sure what was happening 8 years ago. I was ready to buy some shares but i'm concerned the lack of interest means others are seeing what im not. I know a bit about pharmaceuticals and it seems they've got an effective, patented, approved drug. And as others here have said over a decade ago (haha) there's a lot of potential for such a drug.

Had a look and it's interesting. The drug is expensive and I think there are less costly standard drugs based on cortesoids which do have side effects. I read the news letter and the CEO needs an editor. The drug works yet they are burning cash, why?

I think the next annual report will be interesting. If you are in now you may see a good rise when it's released. I will wait to get a comprehensive understanding. they are also on the Nasdaq so when that report will happen I am unsure.

 

[Pugt16]

Had a look and it's interesting. The drug is expensive and I think there are less costly standard drugs based on cortesoids which do have side effects. I read the news letter and the CEO needs an editor. The drug works yet they are burning cash, why?

I think the next annual report will be interesting. If you are in now you may see a good rise when it's released. I will wait to get a comprehensive understanding. they are also on the Nasdaq so when that report will happen I am unsure.

Less costly drugs based on corticoids? I don't know that Scenesse or a-MSH is a corticoid. A peptide hormone yes, and the side effects from what i understand are very mild with limited or no serious side effects to date. I believe side effects are typically facial flushing, nausea, fatigue, redness at site of injection, somewhere in the vicinity of 15-30% rate of incidence.

It is definitely an expressive drug, but most orphan drugs are. Is it too expensive? I don't really know and i guess it is well beyond the means of anyone but the rich and insured.

"The drug works yet they are burning cash, why?" That's a good question, sadly my investor knowledge is lacking when it comes to data analysis.

"I read the news letter and the CEO needs an editor." I find this an extremely interesting comment, what did you see that makes you say that?!

 

[Knobby22]

"I read the news letter and the CEO needs an editor." I find this an extremely interesting comment, what did you see that makes you say that?!

He rambles, uses jargon. He isn't succinct.

That said , when the annual report is released we should be able to work out where the costs are.

 

[greggles]

Clinuvel Pharmaceuticals up $1.23 to $12.03 so far today. Strangely there have been no announcements for a few weeks now.

This one has been a great performer and is currently at all-time highs. Anyone else following it?

 

[kid hustlr]

Well you can lead a horse to water but you can't make it drink.

I've stood idly by not buy(ing) this obvious one.

Starting to get to near ATH now so I'd be a little weary now.

 

[kid hustlr]

Has been a really good trading stock and has burst into new ATH today. No idea what it does but the chart looks good and although very whippy it has 'behaved well' for those who dare play.

I figure it could halve overnight so a pretty good one for the stock tipping thread as it's not my money.

 

[kid hustlr]

Incredibly difficult stock to trade but boy oh boy the long term holders have done ok from this one currently trading 18.80